PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Treatment with Lycopus europaeus significantly increased urinary T4 excretion and diminished specific thyroid-related symptoms, such as increased morning heart rate [PMID: 18083505].
An extract (Thyreogutt mono) was used to control vegetative and irritative symptoms in a general practice setting [PMID: 23247973].
In thyroxine-treated rats, the extract reduced increased heart rate, blood pressure, and raised body temperature [PMID: 16150466].
Safety & adverse effects
Drug interactions
Evidence summary
PubMed sources
- 1.PMID: 18083505 (2008) — Lycopus europaeus (Gypsywort): effects on the thyroidal parameters and symptoms associated with thyroid function. · Phytomedicine : international journal of phytotherapy and phytopharmacology
- 2.PMID: 16150466 (2006) — Extract of Lycopus europaeus L. reduces cardiac signs of hyperthyroidism in rats. · Life sciences
- 3.PMID: 10757737 (2000) — Isopimarane diterpenoids from Lycopus europaeus. · Journal of natural products
- 4.PMID: 20674349 (2010) — Antimicrobial phenolic abietane diterpene from Lycopus europaeus L. (Lamiaceae). · Bioorganic & medicinal chemistry letters
- 5.PMID: 25674680 (2015) — Lycopus europaeus: phenolic fingerprint, antioxidant activity and antimicrobial effect on clinical Staphylococcus aureus strains.